Cells Show Promise for Parkinson's

July 2008
Technology Review;Jul2008, Vol. 111 Issue 4, p92
The article presents a study that assesses the capabilities of brain cells developed from skin cells to alleviate the symptoms and pain in Parkinson's disease. Rudolf Jaenish and colleagues administered the study by transforming mouse skin cells into undifferential cells induced into four different genetic types and integrate in the brain as well as transplanted reprogrammed cells that suppress the release of chemical toxins. The study reveals that reprogrammed cells are capable to function as stem cells which help reduces the symptoms of Parkinson's disease. In addition, the author notes that the research manifest its potentials in treating such diseases wherein embryonic cells are easy to work with.


Related Articles

  • Generation and Transplantation of Dopaminergic Neurons Derived from Embryonic Stem Cells. Khanna, Aparna; Swistowska, Anna Maria; Rao, Mahendra S.; Xianmin Zeng // Current Stem Cell Research & Therapy;May2007, Vol. 2 Issue 2, p139 

    Human embryonic stem cells (hESCs) can be propagated as undifferentiated cells over multiple passages and thus offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Because of the important roles of dopaminergic (DA) neurons in modulating motor...

  • Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. Ganat, Yosif M.; Calder, Elizabeth L.; Kriks, Sonja; Nelander, Jenny; Tu, Edmund Y.; Jia, Fan; Battista, Daniela; Harrison, Neil; Parmar, Malin; Tomishima, Mark J.; Rutishauser, Urs; Studer, Lorenz // Journal of Clinical Investigation;Aug2012, Vol. 122 Issue 8, p2928 

    Embryonic stem cells (ESCs) represent a promising source of midbrain dopaminergic (DA) neurons for applications in Parkinson disease. However, ESC-based transplantation paradigms carry a risk of introducing inappropriate or tumorigenic cells. Cell purification before transplantation may...

  • Will stem cell therapies be safe and effective for treating spinal cord injuries? Thomas, Katharine E.; Moon, Lawrence D. F. // British Medical Bulletin;Jun2011, Vol. 98 Issue 1, p127 

    Introduction A large number of different cells including embryonic and adult stem cells have been transplanted into animal models of spinal cord injury, and in many cases these procedures have resulted in modest sensorimotor benefits. In October 2010 the world's first clinical trial using human...

  • Long-term clinical outcomes after fetal cell transplantation in parkinson disease: implications for the future of cell therapy. Bega, Danny; Krainc, Dimitri // JAMA: Journal of the American Medical Association;2/12/2014, Vol. 311 Issue 6, p617 

    IMPORTANCE: Recent advances in stem cell technologies have rekindled an interest in the use of cell replacement strategies for patients with Parkinson disease. This study reports the very long-term clinical outcomes of fetal cell transplantation in 2 patients with Parkinson disease. Such...

  • ‘Light-chain escape-multiple myeloma’—an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring. Kühnemund, A.; Liebisch, P.; Bauchmüller, K.; zur Hausen, A.; Veelken, H.; Wäsch, R.; Engelhardt, M. // Journal of Cancer Research & Clinical Oncology;Mar2009, Vol. 135 Issue 3, p477 

    More intensive and novel therapy options in multiple myeloma (MM) hold the promise to improve treatment outcome. However, disease evolution, induced with long disease duration and extensive pretreatment, has resulted in changes in the biological behaviour of MM and unusual relapse emergence,...

  • Therapeutic Cloning: The Ethical Road to Regulation Part I: Arguments For and Against & Regulations. Brown, Alistair // Human Reproduction & Genetic Ethics;Sep2009, Vol. 15 Issue 2, p75 

    The article discusses the arguments for regulation in therapeutic cloning which include the creation of embryo and the subsequent use of that embryo. Therapeutic cloning process is a specialized form of stem cell therapy which combines stem cell therapies with cell nuclear replacement. In...

  • Stem-cell-based therapy and lessons from the heart. Passier, Robert; van Laake, Linda W.; Mummery, Christine L. // Nature;5/15/2008, Vol. 453 Issue 7193, p322 

    The potential usefulness of human embryonic stem cells for therapy derives from their ability to form any cell in the body. This potential has been used to justify intensive research despite some ethical concerns. In parallel, scientists have searched for adult stem cells that can be used as an...

  • Human stem cell research and regenerative medicine—present and future. Volarevic, Vladislav; Ljujic, Biljana; Stojkovic, Petra; Lukic, Aleksandra; Arsenijevic, Nebojsa; Stojkovic, Miodrag // British Medical Bulletin;Sep2011, Vol. 99 Issue 1, p155 

    Introduction Stem cells are cells with the ability to grow and differentiate into more than 200 cell types. Sources of data We review here the characteristics and potential of human embryonic stem cells (hESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs). Areas of...

  • Nuclear Magnetic Resonance Detects Phosphoinositide 3-Kinase/Akt-Independent Traits Common to Pluripotent Murine Embryonic Stem Cells and Their Malignant Counterparts. Romanska, Hanna M.; Tiziani, Stefano; Howe, Rachael C.; Günther, Ulrich L.; Gulzar, Zulfiqar; Lalani, El-Nasir // Neoplasia;Dec2009, Vol. 11 Issue 12, p1301 

    Pluripotent embryonic stem (ES) cells, a potential source of somatic precursors for cell therapies, cause tumors after transplantation. Studies of mammalian carcinogenesis using nuclear magnetic resonance (NMR) spectroscopy have revealed changes in the choline region, particularly increased...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics